Metraipolis › archive › dc_d6fbe85bc8a7

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe — Europe PMC PMID:42602164

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42602164
DOI
10.3389/fphar.2026.1864897
License (as archived)
solo-consultazione
Archived
2026-10-17T06:59:49.520Z
SHA-256 of the archived text
d0fe50b63a1f1c1904555f68d1c8a91899136b24fc7f087ab3c3036d990326ad
Stable URL of this page
https://metraipolis.com/documento/dc_d6fbe85bc8a7

How to cite

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe — Europe PMC PMID:42602164 — Europe PMC (en), https://europepmc.org/article/MED/42602164 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d6fbe85bc8a7 (Metraipolis archive dc_d6fbe85bc8a7, sha256 d0fe50b63a1f1c1904555f68d1c8a91899136b24fc7f087ab3c3036d990326ad)
BibTeX
@misc{dcd6fbe85bc8a7,
  title = {Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe — Europe PMC PMID:42602164},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42602164},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d6fbe85bc8a7; sha256 d0fe50b63a1f1c1904555f68d1c8a91899136b24fc7f087ab3c3036d990326ad},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42602164. Agents can read the archived copy with the MCP tool read_document.